RAP charting, page-8390

My questions:

- why make a CR for over 10 Mio. last (!) year?
- why BL sold his shares?
- where are aussi trial results?
- why it takes so long to evaluate trials/results?
I thought its much faster then traditional tests?
- MSF, why they published the name with a TH? What a joke? To cause a jump and to sell the news? They start field trials? I thought they already started trials.
- MC only and still at 200 mio.?

Normally some sell arguments. But the fact that it could be a disruptive tech. I will keep the shares. But it will be very stormy with no idea how this will end.

IMO